SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-282886
Filing Date
2015-08-07
Accepted
2015-08-07 14:51:15
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d52312d10q.htm 10-Q 218537
2 EX-31.1 d52312dex311.htm EX-31.1 9027
3 EX-31.2 d52312dex312.htm EX-31.2 9307
4 EX-32.1 d52312dex321.htm EX-32.1 5361
  Complete submission text file 0001193125-15-282886.txt   1859404

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT hrtx-20150630.xml EX-101.INS 335436
6 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20150630.xsd EX-101.SCH 22980
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20150630_cal.xml EX-101.CAL 19149
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20150630_def.xml EX-101.DEF 153739
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20150630_lab.xml EX-101.LAB 146189
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20150630_pre.xml EX-101.PRE 163463
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 151036863
SIC: 2834 Pharmaceutical Preparations